CARDIOPROGRESS
Foundation for the advancement of cardiology

Noninvasive Approach to Revascularization Decisions Shows Promise When deciding on the optimal revascularization strategy for patients with multivessel coronary disease, a noninvasive approach using quantitative flow ratio (QFR) showed substantial agreement with the more invasive classical fractional flow reserve (FFR) approach in a new study.

SAFE-PAD Shows Long-Term Safety of Paclitaxel Devices Patients who have paclitaxel-coated stents and balloons have survival and outcomes comparable to those who have a bare-metal stent or percutaneous transluminal angioplasty, according to updated results from a large study of almost 170,000 Medicare beneficiaries.

ADT for Prostate Cancer: What's the Risk on the Heart? Androgen deprivation therapy (ADT) for localized prostate cancer increases the risk of myocardial infarction (MI), stroke, and other cardiovascular disease (CVD) events as well as death, according to a study from Norway.

Genetic Test for Six Chronic Diseases Undergoing Clinical Trial A new type of genetic test known as a polygenic risk score could change the way clinicians detect and treat chronic illnesses. But to be widely used, genomic findings in large populations first need to be translated into valid clinical tests for individual patients. Then physicians need meaningful interpretations of test data to help make clinical decisions about patient care.

Greater Triglyceride-Glucose Index Variability Tied to CV Risk The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed.

Smokers With Heart Disease Could Gain 5 Years by Quitting Smoking cessation appears to be comparable to the use of three targeted drugs in warding off future major cardiovascular events in smokers with atherosclerotic cardiovascular disease (ASCVD), according to a new study.

FDA Approves Fitbit's AFib-Detection Software A popular fitness tracker company has received approval from the Food and Drug Administration for a new software algorithm to detect atrial fibrillation (AFib), Fitbit announced on April 11.

The Uphill Struggle for High-Intensity Statins in ASCVD Patients New research suggests physicians face a Herculean task to get Americans with atherosclerotic cardiovascular disease (ASCVD) to take high-intensity statins, despite multiple professional guidelines giving the therapy their highest level recommendation.

Pfizer Recalls BP Drugs Because of Potential Carcinogen Pfizer is voluntarily recalling some antihypertensive medications because of unacceptable levels of a potential carcinogen, the company announced.

Left Atrial Dysfunction Linked to Future Dementia Risk A new study has suggested that left atrial dysfunction could be a risk factor for the future development of dementia, raising the possibility of a new approach to dementia prevention.

Dedicated to eternal memory Dear colleagues!
On these holidays, the Cardioprogress Foundation remembers the heroes of the Great Patriotic War, whose feat was immortalized in the hearts of their descendants.

Spanish Cardiologists Release Gender-Specific CV Guide The Spanish Society of Cardiology (SEC) Working Group on Women and Cardiovascular Diseases (SEC-GT CVD in Women) and the Association of Preventive Cardiology have convened an interdisciplinary group of experts from various Spanish societies and associations issued SEC-approved clinical guidelines published in the English-language edition of the Revista Española de Cardiología journal, which is designed to help medical professionals. in the diagnosis and treatment of cardiovascular diseases in women, paying special attention to gender differences.

Major Indexing Service Calls Out Cardiology Journals for Self-Citation More than 70% of the citations in one journal were to other papers in that journal. Another published a single paper that cited nearly 200 other articles in the journal.

Novel Lipid Therapies: 5 Things to Know The development of novel pharmacotherapies targeting low-density lipoprotein (LDL), lipoprotein a, and triglycerides (TG) to help prevent patients' risk of atherosclerotic cardiovascular disease (ASCVD) has accelerated during the past decade.

COVID-19 and cardiovascular diseases: main aspects Igor S. Yavelov MD, PhD, Professor of cardiology

Administration of patients during and after a coronavirus pandemic. Interview with professor Mekhman N. Mamedov. Dear Colleagues! On April 27, 2021, at the initiative of the Indonesian Society of Cardiology, an online meeting was held with one of the leading experts of Russia in the cardiology, Professor Mekhman N Mamedov.

Hypertension Clinical Practice Guidelines (ISH, 2020) International Society of Hypertension (ISH) The International Society of Hypertension (ISH) released their global recommendations on the management of hypertension in adults aged 18 years and older in June 2020.

Social Isolation Tied to Higher Risk of CV Events, Death Social isolation is associated with an increased risk of a cardiovascular event of more than 40%, and of all-cause mortality approaching 50%, new research suggests.

Hospital Volumes Slashed by More Than Half During Pandemic As US hospitals begin to reopen for elective procedures, a new report outlines the damage that the COVID-19 pandemic has done to the facilities' patient volumes and revenues.

COVID-19: AHA Guidance on Hypertension, Latest on Angiotensin Link The American Heart Association (AHA) has issued new guidance for patients with hypertension during the COVID-19 outbreak. At the same time, several new review articles have been published further exploring the possible relationship between the renin-angiotensin system (RAS) and the virus.